Skip to main content
. Author manuscript; available in PMC: 2019 Jul 3.
Published in final edited form as: Vaccine. 2018 Nov 22;37(1):25–33. doi: 10.1016/j.vaccine.2018.11.048

Table 5.

Estimated hospitalizations and deaths potentially averted in current and target influenza vaccination programs, South Africa, 2016.

Risk group Number vaccinated by current program (% target population) Estimated hospitalizations averted by current program (95% CI) Estimated deaths averted by current program (95% CI) Number vaccinated with target coverage* (% target population) Estimated hospitalizations averted by target program (95% CI) Estimated deaths averted by target program (95% CI)
Pregnant women -and- Infants aged 0–5 months 167,840 (14) 430 (245–676) 26 (15–38) 479,544 (40) 1229 (701–1933) 74 (43–109)
HIV-infected adults aged 15– 64 years 198,141 (3) 378 (49–774) 96 (12–203) 1,320,942(20) 2522 (324–5160) 637 (81–1351)
Children aged 6–23 months 51,885 (3) 58 (1–124) 4 (0–9) 553,441 (32) 618 (6–1319) 44 (1–101)
Adults aged ≥ 65 years 58,182 (2) 65 (41–93) 55 (37–74) 290,912 (10) 323 (205–467) 276 (186–370)
Healthcare workers 56,639 (10) 20 (15–26) 7 (4–11) 453,114 (80) 164 (120–210) 57 (30–85)
Adults and children with TB 9,546 (3) 15 (9–23) 9 (6–12) 63,639 (20) 103 (61–156) 60 (41–81)
Adults and children with other chronic illnesses 295,901 (3) 87 (46–132) 49 (25–84) 1,972,671 (20) 580 (306–882) 329 (164–558)
Total 838,134 (4) 1054 (405–1849) 247 (99–431) 5,134,263 (22) 5,538 (1,722–10,126) 1,478 (545–2,656)
*

Target vaccine coverage derived from 50% coverage with an existing vaccination platform or assumption of 80% coverage of individuals presenting over a 3-month vaccination period.